Find a Research Lab

Colorectal cancer is the most prevalent in GI cancers, causing 600,000 deaths worldwide each year. Ajay Goel Lab is committed to developing better methods for the early detection and precision treatment of cancer.

The Alexey Danilov Lab focuses on early drug development in lymphoid malignancies. See how our research is leading to novel therapeutic approaches.

The Anna Wu Lab is currently researching the development and translation of radiolabeled antibodies for cancer therapy, with an initial focus on prostate and pancreatic cancer

The Brenner Lab dissects the disturbances of the four nicotinamide adenine dinucleotide (NAD) coenzymes — the central catalysts of metabolism — to develop tools that improve health. 

Dr. Querfeld leads a multidisciplinary team of experts who are pioneering treatments for CTCL and its subtypes. Dr. Querfeld’s laboratory investigations are focused on the complex network within the tumor microenvironment (TME) in CTCL funded by NIH-NCI R01 and LLS scholar grants.

The overarching goal of Christine Brown's research program is to develop, optimize and translate chimeric antigen receptor (CAR) T cell therapy for the treatment of cancer, with a particular emphasis on its application to brain tumors.

The Defu Zeng Lab's studies will provide new insights into transplantation biology while promoting the application of HCT as a curative therapy.

The Edwin Manuel lab focuses on novel strategies to enhance delivery of anti-cancer therapy. See our approaches, including the use microbial-based agents.

The Fueger Lab applies an engineer’s eye to the signaling mechanisms that control metabolism in health — and go awry in disease. See our latest research.

The Garcia-Ocana lab focuses on identifying cellular and molecular mechanisms involved in diabetes development and finding effective therapies that can prevent or reverse the disease.